Kirsten Wassermann

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression

Florian Fritzsche, Kirsten Wassermann, Monika Jung et al. · BMC Cancer · 2008 · 86 citations · Full text

Medicine, Oncology, Pathology +17

ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer

Florian Fritzsche, Monika Jung, Angelika Tölle et al. · European Urology · 2007 · 79 citations

Medicine, Oncology, Urology +14

Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer

Dirk Müller, Marion Danner, Rita K. Schmutzler et al. · The European Journal of Health Economics · 2019 · 28 citations

Pharmacy, Oncology, Pharmacoeconomics +17

Psychological factors and the uptake of preventative measures in BRCA1/2 pathogenic variant carriers: results of a prospective cohort study

Julia Dick, Anja Tüchler, Anne Brédart et al. · Hereditary Cancer in Clinical Practice · 2022 · 14 citations · Full text

Life Sciences, Genetics, Oncology +17

CD146 protein in prostate cancer: revisited with two different antibodies

Florian Fritzsche, Kirsten Wassermann, Anja Rabien et al. · Pathology · 2008 · 12 citations

Medicine, Molecular Biology, Oncology +12